Brokerage firm Prabhudas Lilladher has maintained its 'Reduce' rating on Deepak Nitrite with a target price of Rs 1,419. While the company recently reported a strong 235% jump in quarterly profit, analysts are flagging concerns about global oversupply in the phenol market and high stock valuations.
Prabhudas Lilladher has maintained a 'Reduce' rating on Deepak Nitrite, setting a target price of Rs 1,419. This cautious stance arrives shortly after the company announced its financial results for the second quarter of the 2027 fiscal year. The stock closed at Rs 1,519.40 as of October 30, 2026.
Deepak Nitrite’s recent performance shows a split narrative between its business segments. The company reported a consolidated revenue of Rs 3,091 crore, which is a 61% increase compared to the same period last year. Its net profit surged 235% year-on-year to reach Rs 398 crore. This growth was largely powered by the Phenolics segment, which recorded a revenue of Rs 2,291 crore, up 72% from the previous year. High domestic demand and global supply disruptions helped boost profitability in this area.
However, the brokerage’s 'Reduce' rating highlights structural risks that may lie ahead. Analysts point out that the current high profits in the Phenolics segment are partly due to temporary market conditions. As global supply stabilizes and new domestic capacities enter the market, there is a risk that the unusually high price differences currently enjoyed by the company may return to lower, historical levels. This is commonly referred to as margin normalization.
At the same time, the Advanced Intermediates segment has faced difficulties. EBIT, which is a measure of operating profit, dropped in this division due to factors like increased logistics costs and fluctuating input prices. The brokerage suggests that while the company is currently performing well, the stock is trading at a high valuation—approximately 25 times its expected earnings for the 2029 fiscal year—which may not account for these potential risks.
The company is in the middle of a significant expansion plan, including new facilities at its Dahej site. It also has long-term plans to enter the polycarbonate resin market, with full project integration expected only by the 2030 fiscal year. While these projects aim to drive future growth, they also involve significant capital spending and execution timelines that stretch several years into the future.
For investors, the key area to monitor will be the sustainability of the current profit margins in the Phenolics segment. The market will be watching to see if global phenol supply conditions change and how quickly the company’s new capacity in areas like nitric acid and specialty chemicals can start contributing to the bottom line without putting undue pressure on its cash flow.